Suppression of reactive oxygen species develops lymph node metastasis in colorectal cancer

Hepato-Gastroenterology

Volumn 59, Issue 120, 2012, Pages 2480-2483

  Inokuma, Takamitsu ^a   Haraguchi, Masashi ^a,b   Fujita, Fumihiko ^a   Torashima, Yasuhiro ^a   Eguchi, Susumu ^a   Kanematsu, Takashi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

Colorectal cancer; Derivative reactive oxygen metabolites; Lymph node metastasis; Reactive oxygen species

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; REACTIVE OXYGEN METABOLITE;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; CANCER CLASSIFICATION; CANCER INVASION; CANCER PATIENT; CANCER SIZE; COLORECTAL CANCER; FEMALE; GENDER; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; HUMANS; LINEAR MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; OXIDATIVE STRESS; PROGNOSIS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR BURDEN;

EID: 84872062421     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10383     Document Type: Article

References (30)

1. Fruehauf JP, Meyskens FL Jr: Reactive oxygen species: a breath of life or death? Clin Cancer Res 2007; 13:789-794.
2. Pan JS, Hong MZ, Ren JL: Reactive oxygen species: a double-edged sword in oncogenesis. World J Gastroenterol 2009; 15:1702-1707.
3. Wu WS: The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 2006; 25:695-705.
4. Nishikawa M: Reactive oxygen species in tumor metastasis. Cancer Lett 2008; 266:53-59.
5. Nicco C, Laurent A, Chereau C, Weill B, Batteux F: Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother 2005; 59:169-174.
6. López-Lázaro M: Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett 2007; 252:1-8.
7. Ozben T: Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 2007; 96:2181-2196.
8. Wang J, Yi J: Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 2008; 7:1875-1884.
9. Panayiotidis M: Reactive oxygen species (ROS) in multistage carcinogenesis. Cancer Lett 2008; 266:3-5.
10. Roessner A, Kuester D, Malfertheiner P, Schneider-Stock R: Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract 2008; 204:511-524.
11. Rainis T, Maor I, Lanir A, Shnizer S, Lavy A: Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon. Dig Dis Sci 2007; 52:526-530.
12. Lu W, Ogasawara MA, Huang P: Models of reactive oxygen species in cancer. Drug Discov Today Dis Models 2007; 4:67-73.
13. Halliwell B: Oxidative stress and cancer: have we moved forward? Biochem J 2007; 401:1-11.
14. Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T: High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat Res 2007; 631:55-61.
15. Gencer M, Ceylan E, Aksoy N, Uzun K: Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer. Respiration 2006; 73:520-524.
16. Mantovani G, Maceiò A, Madeddu C, et al.: Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment J Cell Mol Med 2002; 6:570-582.
17. Storz P: Reactive oxygen species in tumor progression. Front Biosci 2005; 10:1881-1896.
18. Tatebe S, Sinicrope FA, Kuo MT: Induction of multidrug resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells. Biochem Biophys Res Commun 2002; 290:1427-1433.
19. Niitsu Y, Takayama T, Miyanishi K, et al.: Chemoprevention of colorectal cancer. Cancer Chemother Pharmacol 2004; 54(1):S40-43.
20. Minami T, Adachi M, Kawamura R, Zhang Y, Shinomura Y, Imai K: Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity. Clin Cancer Res 2005; 11:5248-5256.
21. Haraguchi M, Komuta K, Akashi A, et al.: Elevated IL-8 levels in the drainage vein of resectable Dukes' C colorectal cancer indicate high risk for developing hepatic metastasis. Oncol Rep 2002; 9:159-165.
22. Haraguchi M, Komuta K, Akashi A, Furui J, Kanematsu T: Occurrence of hematogenous metastasis and serum levels of thymidine phosphorylase in colorectal cancer. Oncol Rep 2003; 10:1207-1212.
23. Haraguchi M, Komuta K, Ueda T, et al.: Prognostic significance of the serum thymidine phosphorylase levels in venous blood drainage specimens in patients with colorectal cancer. Hepato-gastroenterol 2008; 55:418-421.
24. Inokuma T, Haraguchi M, Fujita F, Tajima Y, Kanematsu T: Oxidative stress and tumor progression in colorectal cancer. Hepato-gastroenterol 2009; 56:343-347.
25. Oberley LW, Buettner GR: Role of superoxide dismutase in cancer: a review. Cancer Res 1979; 39:1141-1149.
26. Nozoe T, Honda M, Inutsuka S, Yasuda M, Korenaga D: Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma. Oncol Rep 2003; 10:39-43.
27. Jessup JM, Samara R, Battle P, Laguinge LM: Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway. Clin Exp Metastasis 2004; 21:709-717.
28. Jessup JM, Laguinge L, Lin S, et al.: Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells. Int J Cancer 2004; 111:332-337.
29. Iwasaki H, Suda T: Cancer stem cells and their niche. Cancer Sci 2009; 100:1166-1172.
30. Hosokawa K, Arai F, Yoshihara H, et al.: Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction. Biochem Biophys Res Commun 2007; 363:578-583.